Optimizing the Use of Virtual Reality in Rehabilitation for Individuals With Persistent Shoulder Pain

NCT07293312 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-12-19

No results posted yet for this study

Summary

The primary objective of this clinical trial is to investigate the effect of a block of four specific virtual reality (VR) exercises on upper limb function, pain, kinesiophobia, and pain catastrophizing in individuals with rotator cuff-related shoulder pain (RCRSP). The secondary objective is to examine participants' tolerability of different VR interventions.

Study Procedures:

Participants will:

* Attend a face-to-face assessment to confirm eligibility and receive a standardized pain neurophysiology education session (week 0).
* Visit the clinic once weekly for four weeks to undergo the VR interventions and review pain education concepts (Weeks 5 to 8).
* Complete online questionnaires evaluating upper limb function, kinesiophobia, pain, sense of presence, and cybersickness.

Interventions

Four VR interventions will be tested:

* Unimanual distraction task with normal visual feedback
* Bimanual distraction task with normal visual feedback
* Unimanual reaching task with augmented visual feedback
* Unimanual reaching task with diminished visual feedback

Findings will guide clinicians in selecting the most effective VR interventions for shoulder impairment and assess the feasibility of implementing VR in a private physiotherapy clinic for individuals with RCRSP.

Conditions

  • Rotator Cuff Related Shoulder Pain

Interventions

OTHER

Virtual reality unimanual distraction task

Unimanual tasks (performed with the affected limb) with unaltered visual feedback will involve distraction exercises in which participants move a tray toward targets while keeping a ball balanced on the tray. Three trials with varying levels of friction between the ball and tray will be presented to manipulate the task's difficulty.

OTHER

Virtual reality bimanual distraction task

Bimanual tasks with unaltered visual feedback (targets positioned based on the affected limb) will involve distraction exercises in which participants move a tray toward targets while keeping a ball balanced on the tray. Three trials with varying levels of friction between the ball and tray will be presented to adjust task difficulty.

OTHER

Virtual reality unimanual reaching tasks with augmented visual feedback

Three trials with varying levels of visual feedback alteration will be performed, corresponding to a 0%, 25%, or 50% amplification of movement in the virtual environment compared to the real world. While virtual targets will appear farther apart, the actual movement required to reach them will remain the same across all trials.

OTHER

Virtual reality unimanual reaching tasks with decreased visual feedback

Three trials with varying levels of visual feedback alteration will be performed, corresponding to a 0%, 17%, or 33% reduction in movement in the virtual environment compared to the real world. Although the virtual targets will appear closer together, the actual movement required to reach them will remain the same across all trials.

Sponsors & Collaborators

  • Laval University

    lead OTHER

Principal Investigators

  • Catherine Mercier, OT,PhD · Centre for Interdisciplinary Research in Rehabilitation and Social Integration (Cirris)

  • Jean-Sébastien Roy, PT, PhD · Centre for Interdisciplinary Research in Rehabilitation and Social Integration (Cirris)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-15
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07293312 on ClinicalTrials.gov